围手术期感染对肾细胞癌肾切除术后肿瘤特异性生存的影响
该回顾性队列研究利用SEER-Medicare数据(2004-2011),纳入8967例65岁以上接受肾切除术的肾细胞癌患者,其中493例(5.5%)术后30天内因感染住院。多变量Cox回归显示感染组肿瘤特异性生存显著改善(HR 0.75,95%CI 0.57-0.99,p=0.04),效应主要见于肿瘤≥7cm患者(HR 0.67,95%CI 0.44-0.99,p=0.049)。
要点
- 肾切除术后30天内因感染住院与肿瘤特异性生存改善相关(多变量HR 0.75,95%CI 0.57-0.99,p=0.04)。
- 生存获益主要见于肿瘤≥7cm患者(HR 0.67,95%CI 0.44-0.99,p=0.049),<7cm患者无显著影响。
- 单变量分析中感染组肿瘤特异性生存改善未达统计学显著(HR 0.84,95%CI 0.69-1.00,p=0.054)。
核心结论
- 在接受肾切除术的T2期(肿瘤≥7cm)肾细胞癌患者中,围手术期感染可能改善肿瘤特异性生存。
研究设计与样本
- 回顾性队列研究,使用SEER-Medicare理赔数据(2004至2011年),纳入8967例65岁以上接受根治性或部分性肾切除术的肾细胞癌患者,其中493例(5.5%)术后30天内因感染住院。
- 排除标准包括术后90天内死亡、免疫缺陷和诊断时转移性疾病。
主要发现
- 中位年龄74岁(IQR 69-79),Elixhauser指数均值±SD为4.9±7.4,中位随访42个月(IQR 22-67)。
- 单变量Cox回归显示,因严重感染需住院的患者肿瘤特异性生存改善未达统计学显著(HR 0.84,95%CI 0.69-1.00,p=0.054)。
- 多变量Cox回归显示,同一人群肿瘤特异性生存显著改善(HR 0.75,95%CI 0.57-0.99,p=0.04)。
- 该效应主要来自肿瘤较大(≥7cm)的患者(HR 0.67,95%CI 0.44-0.99,p=0.049)。
- 肿瘤较小(<7cm)的患者中未观察到影响(HR 0.82,95%CI 0.57-1.19,p=0.3)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Several case reports have documented rare spontaneous cancer regression following systemic infections. Immune related targeted therapies are now available for many cancers, including renal cell carcinoma. We hypothesized that perioperative infection after nephrectomy for renal cell carcinoma may impact long-term cancer specific survival. MATERIALS AND METHODS: We performed a retrospective cohort study using SEER (Surveillance, Epidemiology and End Results)-Medicare claims data from 2004 to 2011. ICD-9 and CPT codes were used to identify patients older than 65 years who underwent radical or partial nephrectomy for renal cell carcinoma. Patients hospitalized for infection within 30 days of surgery were identified. Study exclusion criteria included death within 90 days of surgery, immunodeficiency and metastatic disease at diagnosis. Kaplan-Meier curves were used to evaluate cancer specific survival between infection vs no infection groups. A Cox proportional hazards model was created to assess survival while controlling for age, gender, race, Elixhauser index, tumor grade, tumor size, histological subtype, AJCC (American Joint Committee on Cancer) stage, systemic therapy and geographic region. RESULTS: Of 8,967 patients 493 (5.5%) were hospitalized for infection after nephrectomy. Median age was 74 years (IQR 69-79), the mean ± SD Elixhauser index was 4.9 ± 7.4 and median followup was 42 months (IQR 22-67). Following nephrectomy univariable Cox regression showed a nonsignificant improvement in cancer specific survival in patients with a serious infection requiring hospitalization (HR 0.84, 95% CI 0.69-1.00, p = 0.054). Cox multivariable regression revealed significant improvement in cancer specific survival for the same population (HR 0.75, 95% CI 0.57-0.99, p = 0.04). This effect was primarily due to patients with larger (7 cm or greater) tumors (HR 0.67, 95% CI 0.44-0.99, p = 0.049). No impact was observed among patients with smaller (less than 7 cm) tumors (HR 0.82, 95% CI 0.57-1.19, p = 0.3). CONCLUSIONS: In patients with T2 (7 cm or greater) renal cell carcinoma who undergo nephrectomy perioperative infection may improve cancer specific survival.
引用
- Tallman JE, Pearce SM, Kuchta K, et al. Impact of Perioperative Infection on Cancer Specific Survival after Nephrectomy for Renal Cell Carcinoma. J Urol. 2017. PMID: 28551443. doi:10.1016/j.juro.2017.05.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。